Predictive factors for the outcome of I-131 1110MBq ablation therapy in the patients with differentiated thyroid cancer: urinary iodine, serum thyroglobulin, and uptake to thyroid bed
Predictive factors for the outcome of I-131 1110MBq ablation therapy in the patients with differentiated thyroid cancer: urinary iodine, serum thyroglobulin, and uptake to thyroid bed
复制标题
分化型甲状腺癌患者 I-131 1110MBq 消融治疗结果的预测因素：尿碘、血清甲状腺球蛋白和甲状腺床摄取
DOI：
--
复制
发表时间：
2015
期刊：
影响因子：
--
通讯作者：
and Shinji Naganawa
中科院分区：
文献类型：
--
作者：
Shinji Ito;Shingo Iwano;Katsuhiko Kato;and Shinji Naganawa
